2017 | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2010 | Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study | MAGNETIC RESONANCE IMAGING |
2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
2009 | Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats | GUT |
2021 | Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
| GUT AND LIVER |
2019 | Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
| PLOS ONE |
2013 | Characterization of focal liver masses using acoustic radiation force impulse elastography
| WORLD JOURNAL OF GASTROENTEROLOGY |
2008 | Chronic HBV infection with persistently normal ALT b. not to treat | HEPATOLOGY INTERNATIONAL |
2021 | Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma | HPB |
2016 | Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| CANCER RESEARCH AND TREATMENT |
2012 | Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2022 | Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
| Journal of Liver Cancer(대한간암학회지) |
2011 | Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. | ANTICANCER RESEARCH |
2012 | Clinical characteristics of acute hepatitis A complicated by acute kidney injury | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES |
2021 | Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2008 | Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. | INTERVIROLOGY |
2013 | Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: A case series of 17 patients | JOURNAL OF COSMETIC AND LASER THERAPY |
2010 | Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2012 | Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study | HEPATOLOGY INTERNATIONAL |
2011 | Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2. | JOURNAL OF MEDICAL VIROLOGY |
2011 | Clinical features of re-emerging hepatitis A: an analysis of patients hospitalized during an urban epidemic in Korea.
| YONSEI MEDICAL JOURNAL |
2016 | Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients | JOURNAL OF GASTROENTEROLOGY |
2014 | Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2016 | Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome. | MODERN RHEUMATOLOGY |
2014 | Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2016 | Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2011 | Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea.
| YONSEI MEDICAL JOURNAL |
2015 | Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy | LIVER INTERNATIONAL |
2022 | Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
| GASTROENTEROLOGY REPORT |
2003 | Colorectal flat neoplasia | DIGESTIVE AND LIVER DISEASE |
2012 | Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC | INTERVIROLOGY |
2018 | Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2013 | Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2013 | Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats | APOPTOSIS |
2012 | Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. | INTERNATIONAL JOURNAL OF CANCER |
2016 | Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
| SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2020 | Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2019 | Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
| SCIENTIFIC REPORTS |
2022 | Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
| FRONTIERS IN MEDICINE |
2015 | Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2015 | Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2017 | Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
| ONCOTARGET |
2019 | Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
| CANCER RESEARCH AND TREATMENT |
2014 | Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population | LIVER INTERNATIONAL |
2021 | Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy | HEPATOLOGY INTERNATIONAL |
2011 | Controversies in surveillance and early diagnosis of hepatocellular carcinoma | ONCOLOGY |
2017 | Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2022 | Cost-effectiveness of chronic hepatitis C screening and treatment
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea | CURRENT MEDICAL RESEARCH AND OPINION |
2017 | Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis | AMERICAN JOURNAL OF ROENTGENOLOGY |
2016 | Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY |
2021 | Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
| Journal of Liver Cancer(대한간암학회지) |
2017 | Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis | AMERICAN JOURNAL OF ROENTGENOLOGY |
2017 | Current status and strategies for viral hepatitis control in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2017 | Current status of and strategies for hepatitis C control in South Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Current Status of Therapeutic Choice and Feasibility for Patients with Hepatocellular Carcinoma Aged ≥ 70 Years: A Nationwide Cancer Registry Analysis
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2018 | Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
| GUT AND LIVER |
2020 | Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis C | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |